Back to homepage

Tag "SII CEO Adar Poonawalla"

SII vaccine for 3+ kids by mid-2022, says Adar Poonawalla

SII vaccine for 3+ kids by mid-2022, says Adar Poonawalla

🕔17:47, 14.Dec 2021

Mumbai, Dec 14 (IANS) The Pune-based Serum Institute of India (SII) will launch Covavax — its vaccine for children aged above 3 years — in the next six months, SII CEO Adar Poonawalla said here on Tuesday. Covavax is currently under

Read Full Article
Biocon Biologics offers 15% stake to SII subsidiary for 100 mn vax doses

Biocon Biologics offers 15% stake to SII subsidiary for 100 mn vax doses

🕔10:30, 17.Sep 2021

Bengaluru, Sep 17 (IANS) Biocon Biologics, a subsidiary of Biocon, on Thursday offered approximately 15 per cent stake to Serum Institute Life Sciences (SILS) for 100 million doses of vaccines in a strategic alliance. SILS is a subsidiary of Pune-based Serum

Read Full Article